COMMUNIQUÉS West-GlobeNewswire
-
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
21/10/2024 - 15:00 -
Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219
21/10/2024 - 15:00 -
New employee-elected board member
21/10/2024 - 15:01 -
Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension
21/10/2024 - 15:05 -
Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET
21/10/2024 - 15:09 -
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
21/10/2024 - 15:25 -
Le KFSHRC ouvre la voie aux diagnostics et aux interventions chirurgicales mini-invasives alimentés par l’IA
21/10/2024 - 15:25 -
Innocan Pharma to Present at the 2024 ThinkEquity Conference
21/10/2024 - 15:30 -
The Ensign Group Announces Appointment of Mark Parkinson to the Board of Directors
21/10/2024 - 15:33 -
PetVivo Engages Another Top Sales Manager, Cindy Gill, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide
21/10/2024 - 15:45 -
The Froedtert & MCW Health Network Engages Digital Platform to Roll Out Clinical Nutrition Program to Patients and Employees
21/10/2024 - 16:33 -
Responsibility statement for first half year of 2024
21/10/2024 - 17:00 -
BioPorto A/S Announces Changes to the US Commercial Organization
21/10/2024 - 17:15 -
Valneva effectuera des présentations sur le chikungunya lors de différentes conférences scientifiques de premier plan
21/10/2024 - 17:45 -
Valneva to Present on Chikungunya at Several Leading Scientific Conferences
21/10/2024 - 17:45 -
Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details
21/10/2024 - 17:50 -
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
21/10/2024 - 18:00 -
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees
21/10/2024 - 19:04 -
AAMI, GCEA Translate HTM Guide into Spanish, Chinese, More
21/10/2024 - 19:44
Pages